Help close loopholes in regulating compounders, FDA asks states

The FDA asked state officials to help close gaps in the oversight of compounded drugs following the meningitis outbreak tied to tainted drugs from the New England Compounding Center. The agency's authority should be clear when monitoring the operations of compounding pharmacies, and health officials should act to prevent issues that risk public safety, FDA Commissioner Dr. Margaret Hamburg said. Furthermore, Hamburg said, better training is needed for state regulators, and states and the FDA need to improve sharing of information.

View Full Article in:

Reuters · New York Times (tiered subscription model), The · Tennessean (Nashville) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX
Actuary
Meridian Health Plan
Detroit, MI
Chief Financial Officer
B. E. Smith
Miramar, FL